The new 2021 Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guideline for blood pressure management for adults with CKD who are not receiving dialysis advises treating to a target systolic blood pressure of <120 mmHg, provided measurements are “standardized” and that blood pressure is “measured properly.”
This blood pressure target — largely based on evidence from the Systolic Blood Pressure Intervention Trial (SPRINT) — represents “a major update” from the 2012 KDIGO guideline, which advised clinicians to treat to a target blood pressure of ≤130/80 mmHg for patients with albuminuria or ≤140/90 mmHg for patients without albuminuria.
Source: Medscape